Literature DB >> 26745328

Hyperenhancement of the Pericardium on Cardiac Magnetic Resonance Imaging: A Marker of Acute Inflammation and Neovascularization or a Chronic Fibrotic State.

Liam Mullen1, Pei Gee Chew, Frederick Frost, Ayesha Ahmed, Aleem Khand.   

Abstract

In cardiac magnetic resonance imaging, hyperenhancement of the pericardium post gadolinium administration in acute chest pain often signifies pericarditis with an acute inflammatory response and neovascularization. In the context of constrictive pericarditis, case series have indicated that the intensity of hyperenhancement and the thickness of the pericardium imply reversibility of the physiology of the constrictive pericarditis. We present a case of intense hyperenhancement and marked thickening of the pericardium in a patient with constrictive pericarditis with antecedent chest pain. Surgical resection of the pericardium and microscopy revealed a chronic fibrotic state with no evidence of inflammation or neovascularization, thus clarifying the failure of initial medical/anti-inflammatory treatment. Our case highlights the fact that hyperenhancement of the pericardium post gadolinium is non-specific for histology and does not necessarily imply the reversibility of pericardial constriction.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 26745328     DOI: 10.1159/000442409

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  2 in total

Review 1.  Multimodality Imaging of Pericardial Diseases.

Authors:  Mouaz H Al-Mallah; Fatimah Almasoudi; Mohamed Ebid; Amjad M Ahmed; Abdelrahman Jamiel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-10-12

2.  Refractory Recurrent Pericarditis After Pericardiectomy in a Young Woman.

Authors:  Hassan Mehmood Lak; Chris M Anthony; Muhammad M Furqan; Beni Rai Verma; Mohamed Gad; Sanchit Chawla; Farah Yasmin; Deborah H Kwon; Douglas R Johnston; Allan L Klein
Journal:  JACC Case Rep       Date:  2021-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.